Spots Global Cancer Trial Database for FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma
Official Title: Molecular Correlates and Clinical Significance of Positron Emission Tomography With FET-PET in Combination With Perfusion-weighted Magnetic Resonance Imaging (PWI) in Patients With Low Grade Gliomas
Study ID: NCT01089244
Interventions
Study Description
Brief Summary: The aim of the study is to compare the two imaging modalities perfusion weighted MR-imaging and FET-PET in their ability to provide an accurate histological evaluation of low grade glioma and to reveal focal abnormalities within a homogeneously appearing tumor. Additionally, therapeutic effects should be assessed during a time period of two years.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University Hospital Munich, Department of Neurosurgery, Munich, Bavaria, Germany
University Hospital, Duesseldorf, Duesseldorf, North Rhine-Westphalia, Germany
Contact Details
Name: Joerg C. Tonn, Prof. Dr.
Affiliation: Department of Neurosurgery, LMU Munich
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
